Remitting seronegative symetrical synovitis with pitting edema. One case report
Main Article Content
Keywords
Arthritis, Seronegative, Fovea, Synovitis, RS3PE
Abstract
Background: RS3PE (remitting seronegative symmetrical synovitis with edema and pitting) is a rare entity of unknown etiology that has been related to genetic predisposition due to the presence of HLA-A2 in 50% of cases and less frequently HLA-B7. Its pathogenesis is unknown, but it has been related to growth factors, and some mediators (TNF, IL-6). It is common in elderly people and the course of this illness presents with acute symmetrical polyarthritis, accompanied by edema in hands and feet. The diagnosis requires a high index of suspicion and to differentiate it from other entities such as rheumatoid arthritis, complex regional pain syndrome, rheumatic polymyalgia, in addition to ruling out malignant neoplasms, since there are many reports of its association with both solid and hematological neoplasms, being of bad prognosis when there is association. When there is no association with cancer, it responds well to the use of low doses of steroids and its prognosis is usually favorable.
Clinical case: 80-year-old woman with an acute onset with polyarthralgia, functional limitation associated with pitting edema in hands and feet. After approaching the patient and ruling out associated neoplasms, it was diagnosed RS3PE. It was managed with prednisone, observing a good response, with remission of the manifestations at 6 weeks and subsequent suspension of the steroid.
Conclusions: RS3PE is a rare entity, and a high index of suspicion is required for the diagnosis. A complete approach is important to rule out cancer in patients affected with this syndrome. Prednisone continues to be the best therapeutic option.
References
Pineda-Galindo LF, Hernández-Martínez C. Síndrome RS3PE (sinovitis simétrica seronegativa remitente con edema) o síndrome de McCarty. Med Int Mex. 2020;36(5):730-4.
Ruiz J, Demelo-Rodríguez P, Nuevo J, Cano-Ballesteros J. Síndrome RS3PE: descripción de un caso y revisión de la literatura, Rev Esp Geriatr Gerontol. 2014;49(6):299-303.
Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M et al. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Annals of Rheumatic Disease. 2005; 64(11)1653-5. doi: 10.1136/ard.2004.032995.
Yi C, Liang C, Shinn H, Der-Yuan C, Hidenori A. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: A case report. Journal of Clinical Gerontology and Geriatrics. 2011;2(1):27-9. doi: 10.1016/j.jcgg.2011.01.001.
Li H, Altman D, Yao Q. RS3PE: Clinical and Research Development. Curr Rheumatol Rep. 2015;17(8):49.
Agarwal V, Dabra AK, Kaur R, Sachdev A, Singh R. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: ultrasonography as a diagnostic tool. Clin Rheumatol. 2005;24(5):476-9. doi: 10.1007/s10067-004-1061-x.
Paira S, Graf C, Roverano S, Rossini J. Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases. Clin Rheumatol. 2002;21(2):146-9.
Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L, et al. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis. 1999;58 (4):230-6.
Sibilia J, Friess S, Schaeverbeke T, Maloisel F, Bertin P, Goichot B, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? J Rheumatol. 1999;26(1):115-20.
Azar L, Khasnis A. Paraneoplastic rheumatologic syndromes. Curr Opin Rheumatol. 2013;25(1):44-9. doi: 10.1097/ BOR.0b013e328359e780.
Russell EB. Remitting seronegative symmetrical synovitis with pitting edema syndrome: followup for neoplasia. J Rheumatol. 2005;32(9):1760-1.
Bucaloiu ID, Olenginski TP, Harrington TM. Remitting seronegative symmetrical synovitis with pitting edema syndrome in a rural tertiary care practice: a retrospective analysis. Mayo Clin Proc. 2007;82:1510-5.
Kimura M, Tokuda Y, Oshiawa H, Yoshida K, Utsunomiya M, Kobayashi T, et al. Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica. J Rheumatol. 2012;39:148-53.
Lakhmalla M, Dahiya DS, Kichloo A, Fatima T, Edigin E, Wani F. Remitting seronegative symmetrical synovitis with pitting edema: a review. J Investig Med. 2021;69(1):86-90. doi: 10.1136/jim-2020-001613.
Yajima S, Ooeda T, Inoue M, Suzuki H, Matsumoto S, Masuda H. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE), improved following surgical resection of prostatic carcinoma: A case report. Urology Case Reports. 2020(32),2214-20. doi: 10.1016/j.eucr.2020.101232.
Hegazi MO, Saleh F, Al Rashidi A, Yaktien MM. Synovitis with pitting edema as the presenting manifestation of systemic lupus erythematosus. Lupus. 2014;23:1069-72.
Billey T, Navaux F, Lassoued S. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) as the first manifestation of periarteritis nodosa. Report of a case. Rev Rhum Engl Ed. 1995;62:53-4.
Karmacharya P, Donato AA, Aryal MR, Ghimire S, Pathak R, Shah K, et al. RS3PE revisited: a systematic review and meta-analysis of 331 cases. Clin Exp Rheumatol. 2016;34(3):404-15.
Olivo D, D’Amore M, Lacava R, Rossi MG, Gareri P, Fiorentini C, et al. Benign edematous polysynovitis in the elderly (RS3PE syndrome). Clin Exp Rheumatol. 1994;12(6):669-73.
Amodeo M, Poyato M, Rodríguez M. El síndrome RS3PE: actualización de su tratamiento a propósito de un caso. Semergen. 2015;41(8):429-34.
Hegazi MO, Saleh F, Al Rashidi A, Yaktien MM. Synovitis with pitting edema as the presenting manifestation of systemic lupus erythematosus. Lupus. 2014;23(10):1069-72. doi: 10.1177/0961203314533601.
Yi C, Liang C, Shinn H, Der-Yuan C, Hidenori A. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: A case report. Journal of Clinical Gerontology and Geriatrics. 2011;2(1):27-9. doi: 10.1016/j.jcgg.2011.01.001.
Alba I, Perez M, Vicente O. RS3PE: a propósito de un caso. Atención Primaria. 2021(53)3:101978. doi: 10.1016/j. aprim.2021.101978.
Sato H, Yamada S, Muraoka S, Masuoka S, Kawazoe M, Nanki T. Treatment of Refractatory RS3PE Syndrome with Tocilizumab. J Clin Rheumatol. 2021;27(8S):S814. doi: 10.1097/RHU.0000000000001451.
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.